CA Stock MarketDetailed Quotes

CSCI Cosciens Biopharma Inc

Watchlist
  • 4.150
  • -0.080-1.89%
15min DelayTrading Nov 19 14:09 ET
12.93MMarket Cap-1129P/E (TTM)

Cosciens Biopharma Inc Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Business Currency:USD
2023/FY
Stock NameRevenueRatio
Active Ingredient Product Technology Industry7.26M100.00%
Product

No Data

Industry

No Data

Region Currency:USD
2023/FY
Stock NameRevenueRatio
Germany3.62M49.90%
United States3.47M47.80%
Other134.07K1.85%
Canada24.38K0.34%
China8.07K0.11%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CA
Overall
Symbol
Latest Price
% Chg

No Data